scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1006289298 |
P356 | DOI | 10.1186/1471-2407-14-432 |
P932 | PMC publication ID | 4065589 |
P698 | PubMed publication ID | 24928086 |
P5875 | ResearchGate publication ID | 263096944 |
P2093 | author name string | Dagny L Sandnes | |
Thoralf Christoffersen | |||
Ingun H Tveteraas | |||
John Ødegård | |||
Monica Aasrum | |||
Ingvild J Brusevold | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells | Q24318727 | ||
Cell signaling by receptor tyrosine kinases | Q24598357 | ||
LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor | Q27310850 | ||
Met, metastasis, motility and more | Q28235183 | ||
LPA receptors: subtypes and biological actions | Q28269613 | ||
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression | Q28299091 | ||
Microenvironmental regulation of metastasis | Q29547660 | ||
Seven-transmembrane receptors | Q29619896 | ||
Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells | Q30010057 | ||
Activity of 2-Substituted Lysophosphatidic Acid (LPA) Analogs at LPA Receptors: Discovery of a LPA1/LPA3 Receptor Antagonist | Q30308302 | ||
Role of LPA4/p2y9/GPR23 in negative regulation of cell motility | Q30440331 | ||
Structure-function of the G protein-coupled receptor superfamily | Q30576993 | ||
Chemotaxis in cancer | Q30578627 | ||
Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. | Q33753311 | ||
Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells | Q34036069 | ||
Epidermal growth factor receptor: mechanisms of activation and signalling. | Q34185055 | ||
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades | Q34225939 | ||
Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction | Q34307627 | ||
LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells | Q35046383 | ||
Isoelectric focusing technology quantifies protein signaling in 25 cells. | Q35102405 | ||
EGFR signal transactivation in cancer cells | Q35594162 | ||
Lysophospholipid G protein-coupled receptors | Q35692411 | ||
The extracellular matrix in oral squamous cell carcinoma: friend or foe? | Q36464327 | ||
Epidermal growth factor receptor biology in head and neck cancer | Q36500973 | ||
Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis | Q36664243 | ||
Protein kinase C and other diacylglycerol effectors in cancer | Q36769838 | ||
The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells | Q36847992 | ||
Metastasis of squamous cell carcinoma of the oral tongue | Q36928038 | ||
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells | Q37289059 | ||
G protein-coupled receptors stimulation and the control of cell migration | Q37403166 | ||
Biological roles of lysophosphatidic acid signaling through its production by autotaxin | Q37736787 | ||
Jekyll and Hyde: the role of the microenvironment on the progression of cancer | Q37815128 | ||
The molecular biology of head and neck cancer | Q37821229 | ||
G protein-coupled receptors: novel targets for drug discovery in cancer | Q37824814 | ||
Autotaxin and LPA receptor signaling in cancer | Q37946291 | ||
Current progress in non-Edg family LPA receptor research | Q38035634 | ||
Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells | Q39184225 | ||
Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells | Q39281043 | ||
Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI‐3 kinase/Akt | Q39380720 | ||
Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models | Q39458550 | ||
Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation | Q39702456 | ||
Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation | Q39782375 | ||
LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites | Q39897898 | ||
LPA receptor 2 mediates LPA-induced endometrial cancer invasion | Q39914739 | ||
LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells | Q40133987 | ||
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells | Q40168446 | ||
Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity | Q40608764 | ||
Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors | Q40633092 | ||
Signal characteristics of G protein-transactivated EGF receptor | Q41960343 | ||
Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor | Q42049112 | ||
Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. | Q42471757 | ||
Lysophosphatidic Acid signals through specific lysophosphatidic Acid receptor subtypes to control key regenerative responses of human gingival and periodontal ligament fibroblasts. | Q43298340 | ||
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma | Q43653545 | ||
Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation | Q44203840 | ||
Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes | Q50950996 | ||
Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption. | Q54348437 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell migration | Q189092 |
P304 | page(s) | 432 | |
P577 | publication date | 2014-06-13 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells | |
P478 | volume | 14 |
Q100946289 | B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation |
Q37252696 | CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer |
Q54987153 | Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion. |
Q92535339 | Lysophosphatidic acid guides the homing of transplanted olfactory ensheathing cells to the lesion site after spinal cord injury in rats |
Q38834081 | Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells |
Q38517084 | Mechanisms of Invasion in Head and Neck Cancer |
Q91758816 | Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylation |
Q38933728 | Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression |
Q38817086 | PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells |
Q30400167 | Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3. |
Q89172192 | Role of autotaxin in cancer stem cells |
Q26771727 | Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research |
Q97544399 | Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma |